Results 161 to 170 of about 214,511 (232)

Efficacy and Safety Assessment of Antifungal Prophylaxis with Posaconazole Using Therapeutic Drug Monitoring in Pediatric Patients with Oncohematological Disorders-A Single-Centre Study. [PDF]

J Fungi (Basel)
Liszka K, Marschollek P, Przystupski D, Frączkiewicz J, Mielcarek-Siedziuk M, Olejnik I, Gamrot Z, Haze N, Kwella A, Zalewska P, Resztak M, Ussowicz M, Kałwak K.   +12 more
europepmc   +1 more source

Invasive fungal disease and antifungal prophylaxis in children with acute leukaemia: a multicentre retrospective Australian cohort study. [PDF]

Lancet Reg Health West Pac
Yeoh DK, Blyth CC, Clark JE, Abbotsford J, Corrente C, Cook S, Kotecha RS, Wang SS, Spelman T, Slavin MA, Thursky KA, Haeusler GM.   +11 more
europepmc   +1 more source

Antifungal Prophylaxis Utilization and the Associated Clinical Outcomes Among Pediatric Patients with Hematological Malignancies or Undergoing Hematopoietic Stem Cell Transplantation. [PDF]

J Clin Med
Al Siyabi B, Al-Maqbali JS, Unnikrishnan Meenakshi D, Wali Y, Al Yazidi L.   +4 more
europepmc   +1 more source

Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection. [PDF]

Open Forum Infect Dis
Ross JA, Lee B, Ma H, Tegtmeier B, Nanayakkara D, Dickter J, Spielberger R, Smith E, Pullarkat V, Forman SJ, Taplitz R, Nakamura R, Al Malki M, Dadwal SS.   +13 more
europepmc   +1 more source

Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort. [PDF]

Transplant Cell Ther
Melica G, Luna de Abia A, Shah GL, Devlin S, Corona M, Fein J, Dahi PB, Giralt SA, Lin RJ, Palomba ML, Parascondola A, Park J, Salles G, Saldia A, Scordo M, Shouval R, Perales MA, Seo SK.   +17 more
europepmc   +1 more source

Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT. [PDF]

Microorganisms
Gatti M, Campoli C, Muratore E, Belotti T, Masetti R, Lanari M, Viale P, Pea F.   +7 more
europepmc   +1 more source

Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study. [PDF]

Indian J Hematol Blood Transfus
Metan G, Çiftçioğlu A, Saba R, Kılıç AU, Özdemir K, Çağ Y, Ünal DK, Aksoy F, Berk H, Mert G, Tunçcan ÖG, Tombak A, Balkan İİ, Çavuş SA, Kandemir B, Mutlu B, İnkaya AÇ, Kaynar L, Atay MH, Dursun FE, Saydam G, Ünsal Y, Sarı SF, Akan H, Study group.   +24 more
europepmc   +1 more source

Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients on Universal Antifungal Prophylaxis. [PDF]

Open Forum Infect Dis
Huggins JP, Arthur D, Chow SC, Pease R, Stanly K, Workman A, Reynolds J, Alexander BD.   +7 more
europepmc   +1 more source

COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis. [PDF]

Mycopathologia
Frost J, Gornicec M, Reisinger AC, Eller P, Hoenigl M, Prattes J.   +5 more
europepmc   +1 more source